Zuleima Aguilar

Johnson & Johnson (United States) — United States

Medicine · Health Sciences

8h-index941citations13works7.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(5), Monoclonal and Polyclonal Antibodies Research(4), PI3K/AKT/mTOR signaling in cancer(2), Chronic Lymphocytic Leukemia Research(2), Tuberculosis Research and Epidemiology(1)

Publications13 total

At-Home Evaluation of Both Wearable and Touchless Digital Health Technologies for Measuring Nocturnal Scratching in Atopic Dermatitis: Analytical Validation Study
Journal of Medical Internet Research·2025Open Access
Bedaquiline Monotherapy for Multibacillary Leprosy
New England Journal of Medicine·2024· 9 cited
Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study
Neuropsychopharmacology·2024· 14 citedOpen Access
A Phase 1 First‐in‐Human Pharmacokinetic and Pharmacodynamic Study of JNJ‐64264681, a Covalent Inhibitor of Bruton's Tyrosine Kinase
Clinical Pharmacology in Drug Development·2023· 3 citedOpen Access
OA10.06 A First-in-Human Phase 1 Trial of the EGFR-cMET Bispecific Antibody JNJ-61186372 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology·2018· 8 citedOpen Access
Abstract CT309: Rapid evaluation of a novel small molecule cMet tyrosine kinase inhibitor in healthy subjects
Cancer Research·2015· 3 cited
Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia
Journal of Pharmacology and Experimental Therapeutics·2015· 80 cited
Clinical Development of Sunitinib Malate
2007· 1 cited
Quantitative Association Between HER-2/neu and Steroid Hormone Receptors in Hormone Receptor-Positive Primary Breast Cancer
JNCI Journal of the National Cancer Institute·2003· 589 citedOpen Access
The Transmembrane Heregulin Precursor Is Functionally Active
Journal of Biological Chemistry·2001· 27 citedOpen Access
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells
Oncogene·1999· 144 cited
Alteration of lipid order profile and permeability of plasma membranes from Trypanosoma cruzi epimastigotes grown in the presence of ketoconazole
Molecular and Biochemical Parasitology·1988· 44 cited
The phosphofructokinase of Trypanosoma (Schizotrypanum) cruzi: purification and kinetic mechanism
Molecular and Biochemical Parasitology·1986· 19 cited

Frequent Co-authors

Sandra R. Chaplan(5), Dennis J. Slamon(3), Mark D. Pegram(2), Robin Halter(2), Julio A. Urbina(2), Dawn Millington(2), James A. Palmer(2), Gottfried E. Konecny(1), Giovanni M. Pauletti(1), Michael Untch(1), Sugandha Dandekar(1), Carol Wilson(1), Hong-Mei Rong(1), Ingo Bauerfeind(1), M. Felber(1), H.-J. Wang(1), Malgorzata Beryt(1), R. Seshadri(1), H. Hepp(1), Robert W. Akita(1)